Tiny implant shows promise for glaucoma control during cataract surgery
NCT ID NCT05062668
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether placing a tiny device called iStent during cataract surgery helps lower eye pressure in people with primary open-angle glaucoma. Researchers compared 80 patients who got the implant plus cataract surgery to those who had cataract surgery alone. The goal was to see if the implant safely improves pressure control over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iStent inject or inject W implant
- What this could lead to
- If successful, this could offer a safer way to lower eye pressure in glaucoma patients during cataract surgery, reducing the need for eye drops or more invasive surgery.
- What could go wrong
- This is a small, completed observational study, not a large randomized trial. The implant may not lower pressure enough for all patients, and long-term benefits or risks are not fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Nord
Amiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.